Pfizer and Moderna Raise Vaccine Prices

With the COVID-19 pandemic, there are many situations in which the law of supply and demand applies. Although several pharmaceutical companies are making the COVID-19 vaccine today, there is information indicating that Pfizer and Moderna have raised vaccine prices.

Find out how popular each vaccine is, according to a Financial Times investigation.

A dose of Pfizer costs € 19.50 and Moderna currently costs € 21.48.

Pfizer and Moderna have raised prices for their COVID-19 vaccines, according to the Financial Times (FT). According to the information, in the latest supply contracts with the European Union (EU), the Pfizer vaccine has risen in price by 25%, and Moderna - by 13%.

The price of a Pfizer vaccine dose rose from the current € 15.5 to € 19.50, according to the parts of the contract that the Financial Times had access to, while the price of the Moderna vaccine dose rose to € 21 48. ($ 25.50) compared to the previous € 19 ($ 22.60) in the first purchase agreement.

Despite this increase, the price of the vaccine at Moderna will be even higher, namely 24 euros ($ 28.50), according to the FT, but the price was eventually revised due to the increase in the order.

Given the demand, drug makers are increasing profits as orders for a possible third dose of COVID-19 in winter grow from several countries.

Pharmaceutical sector consultants pointed out in the article that Pfizer, which shares profits with Germany's BioNTech, is expected to generate $ 56 billion (€ 47.2 billion) from the sale of its vaccine by 2022. Moderna is expected to generate approximately $ 30 billion (€ 25.2 billion). billion euros).

As for AstraZeneca, which supplies its vaccine at cost indefinitely to developing countries, the newspaper cites profits in the order of $ 15 billion (€ 12.6 billion).